What one share of Vor Biopharma holds
Vor Biopharma, Inc. ("Vor Bio") is a clinical-stage biopharmaceutical company focused on developing a novel therapy in the treatment of autoimmune diseases. In June 2025, we in-licensed telitacicept from RemeGen Co., Ltd.
Vor Biopharma’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Profit | $20.32 |
|---|---|
| Capex (buildings and equipment) | $0.02 |
| Free cash flow | −$4.56 |
| Cash and investments | $8.56 |
| Book value | −$3.68 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2021 | — | −$41.95 | $2.33 | −$43.69 | — | $116.35 |
| 2022 | — | −$46.57 | $4.28 | −$47.33 | — | $75.95 |
| 2023 | — | −$35.08 | $0.32 | −$30.17 | — | $44.40 |
| 2024 | — | −$34.03 | $0.07 | −$29.08 | — | $15.49 |
| 2025 | — | −$70.50 | $0.10 | −$14.55 | — | −$4.24 |
Common questions about Vor Biopharma
How much does one share of Vor Biopharma earn?
Over the last 12 months, each share of Vor Biopharma earned $20.32 of profit.
Does Vor Biopharma pay a dividend?
Vor Biopharma didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is Vor Biopharma’s book value per share?
Vor Biopharma’s book value is negative (−$3.68 per share): it owes more than everything it owns is recorded at, often after years of buying back its own shares, as of June 30, 2026.
How much cash and debt does each share of Vor Biopharma have?
Each share of Vor Biopharma has $8.56 of cash and investments, as of June 30, 2026.
What is Vor Biopharma’s free cash flow per share?
−$4.56 per share over the last 12 months. Free cash flow is the cash left over after spending on buildings and equipment.
Has Vor Biopharma bought back shares?
Vor Biopharma’s share count rose about 491% from 2021 to 2025. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.